GlassScriptPhysician profile
Lauren Tableman
NPI 1821423674
$4,182.93
in general payments reported to CMS, 2019-2025
15 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,431 · 2024: $2,306 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,177 · Education: $6.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,176.78 |
| Education | $6.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $771.56 | 2023-2025 | Sunosi, Auvelity |
| Alkermes, INC. | $593.12 | 2023-2024 | Aristada, Lybalvi |
| Abbvie INC. | $499.60 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $473.63 | 2023-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Lundbeck LLC | $414.53 | 2023-2025 | Rexulti, Abilify Maintena |
| Teva Pharmaceuticals USA, INC. | $393.27 | 2023-2025 | Austedo Xr, Austedo, Austedo Xr |
| Vanda Pharmaceuticals INC. | $295.74 | 2024-2025 | Fanapt, Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $252.63 | 2023-2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $123.15 | 2023-2025 | Trintellix |
| Idorsia Pharmaceuticals US INC | $112.29 | 2023-2024 | Quviviq |
| Neurocrine Biosciences, INC. | $74.69 | 2023-2024 | Ingrezza |
| Almatica Pharma LLC | $62.68 | 2023-2024 | Loreev Xr |
| Corium, LLC | $57.53 | 2024-2025 | Azstarys |
| Indivior INC. | $39.59 | 2023 | Perseris |
| Merck Sharp & Dohme LLC | $18.92 | 2023 | Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Tableman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.